ATryn Drug Interactions
Currently displaying a list of 120 drugs known to interact with ATryn (antithrombin (recombinant)).
- 38 major drug interactions
- 76 moderate drug interactions
- 6 minor drug interactions
Medications known to interact with ATryn
Note: Showing generic names only.
A
B
C
- cabozantinib
- cangrelor
- caplacizumab
- capsicum
- celecoxib
- chamomile
- citalopram
- clomipramine
- clove
- collagenase clostridium histolyticum
D
- dabigatran
- dalteparin
- danaparoid
- deferasirox
- defibrotide
- deoxycholic acid
- desvenlafaxine
- dexfenfluramine
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- diflunisal
- donanemab
- dong quai
- drotrecogin alfa
- duloxetine
E
F
- fenfluramine
- fenoprofen
- fenugreek
- feverfew
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
G
H
I
K
L
M
N
O
P
- panobinostat
- paroxetine
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- pirtobrutinib
- plasminogen, human
- ponatinib
- prasugrel
R
S
- selumetinib
- sertraline
- sibutramine
- sodium iodide i-123
- sodium iodide-i-131
- sugammadex
- sulindac
- suprofen ophthalmic
T
- tafasitamab
- ticagrelor
- tinzaparin
- tolmetin
- tositumomab
- tovorafenib
- tranexamic acid
- treprostinil
- turmeric
V
Z
ATryn disease interactions
There is 1 disease interaction with ATryn (antithrombin (recombinant)) which include:
More about ATryn (antithrombin (recombinant))
- ATryn consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.